Cargando…
Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial
OBJECTIVE: Describe the effects of the COVID-19 pandemic on subject enrollment in a multicenter randomized controlled trial. STUDY DESIGN: We assessed the number of eligible infants approached and consented for enrollment over five separate epochs including baseline, peak pandemic, and gradual but i...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798371/ https://www.ncbi.nlm.nih.gov/pubmed/36581761 http://dx.doi.org/10.1038/s41372-022-01592-2 |
_version_ | 1784860896007290880 |
---|---|
author | Abu Jawdeh, Elie G. Hunt, Carl E. Eichenwald, Eric Corwin, Michael J. McEntire, Betty Heeren, Timothy Crowell, Lisa M. Ikponmwonba, Christine Saroufim, Ariana Kerr, Stephen |
author_facet | Abu Jawdeh, Elie G. Hunt, Carl E. Eichenwald, Eric Corwin, Michael J. McEntire, Betty Heeren, Timothy Crowell, Lisa M. Ikponmwonba, Christine Saroufim, Ariana Kerr, Stephen |
author_sort | Abu Jawdeh, Elie G. |
collection | PubMed |
description | OBJECTIVE: Describe the effects of the COVID-19 pandemic on subject enrollment in a multicenter randomized controlled trial. STUDY DESIGN: We assessed the number of eligible infants approached and consented for enrollment over five separate epochs including baseline, peak pandemic, and gradual but incomplete recovery. RESULT: The pandemic had a major effect on ability to approach parents for consent. Parents approached dropped from 95.4% baseline to 13.1% in the peak pandemic epoch and has not recovered to baseline even in the just-completed post-pandemic epoch (84.9%). Despite the decrease in subjects approached, there was no significant change in the overall consent rate for the study CONCLUSION: The pandemic has significantly limited ability to approach parents of eligible infants for consent, with only partial recovery. Opportunities for interactions of investigators and study coordinators with parents continue to present challenges limiting full recovery. |
format | Online Article Text |
id | pubmed-9798371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-97983712022-12-29 Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial Abu Jawdeh, Elie G. Hunt, Carl E. Eichenwald, Eric Corwin, Michael J. McEntire, Betty Heeren, Timothy Crowell, Lisa M. Ikponmwonba, Christine Saroufim, Ariana Kerr, Stephen J Perinatol Article OBJECTIVE: Describe the effects of the COVID-19 pandemic on subject enrollment in a multicenter randomized controlled trial. STUDY DESIGN: We assessed the number of eligible infants approached and consented for enrollment over five separate epochs including baseline, peak pandemic, and gradual but incomplete recovery. RESULT: The pandemic had a major effect on ability to approach parents for consent. Parents approached dropped from 95.4% baseline to 13.1% in the peak pandemic epoch and has not recovered to baseline even in the just-completed post-pandemic epoch (84.9%). Despite the decrease in subjects approached, there was no significant change in the overall consent rate for the study CONCLUSION: The pandemic has significantly limited ability to approach parents of eligible infants for consent, with only partial recovery. Opportunities for interactions of investigators and study coordinators with parents continue to present challenges limiting full recovery. Nature Publishing Group US 2022-12-29 2023 /pmc/articles/PMC9798371/ /pubmed/36581761 http://dx.doi.org/10.1038/s41372-022-01592-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Abu Jawdeh, Elie G. Hunt, Carl E. Eichenwald, Eric Corwin, Michael J. McEntire, Betty Heeren, Timothy Crowell, Lisa M. Ikponmwonba, Christine Saroufim, Ariana Kerr, Stephen Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial |
title | Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial |
title_full | Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial |
title_fullStr | Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial |
title_full_unstemmed | Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial |
title_short | Adverse effects of COVID-19 pandemic on a multicenter randomized controlled trial |
title_sort | adverse effects of covid-19 pandemic on a multicenter randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798371/ https://www.ncbi.nlm.nih.gov/pubmed/36581761 http://dx.doi.org/10.1038/s41372-022-01592-2 |
work_keys_str_mv | AT abujawdehelieg adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial AT huntcarle adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial AT eichenwalderic adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial AT corwinmichaelj adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial AT mcentirebetty adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial AT heerentimothy adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial AT crowelllisam adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial AT ikponmwonbachristine adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial AT saroufimariana adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial AT kerrstephen adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial AT adverseeffectsofcovid19pandemiconamulticenterrandomizedcontrolledtrial |